Market Closed -
Japan Exchange
02:00:00 2024-04-26 am EDT
|
5-day change
|
1st Jan Change
|
5,948
JPY
|
+0.93%
|
|
+1.00%
|
+32.95%
|
Fiscal Period: April |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
313,179
|
213,628
|
215,044
|
205,143
|
198,133
|
208,373
|
-
|
-
|
Enterprise Value (EV)
1 |
277,045
|
173,535
|
171,777
|
153,881
|
160,060
|
161,469
|
153,271
|
143,629
|
P/E ratio
|
34.7
x
|
23.3
x
|
32.1
x
|
29
x
|
21.5
x
|
20
x
|
19.9
x
|
17.7
x
|
Yield
|
0.62%
|
0.91%
|
0.91%
|
0.94%
|
1.06%
|
1.03%
|
1.09%
|
1.22%
|
Capitalization / Revenue
|
1.14
x
|
0.73
x
|
0.72
x
|
0.65
x
|
0.55
x
|
0.53
x
|
0.49
x
|
0.47
x
|
EV / Revenue
|
1.01
x
|
0.59
x
|
0.58
x
|
0.49
x
|
0.45
x
|
0.41
x
|
0.36
x
|
0.32
x
|
EV / EBITDA
|
11.5
x
|
7.08
x
|
8.76
x
|
6.39
x
|
6.19
x
|
5.36
x
|
5.15
x
|
4.48
x
|
EV / FCF
|
-53.3
x
|
14.6
x
|
19
x
|
12.6
x
|
19.2
x
|
20.8
x
|
26.2
x
|
19.4
x
|
FCF Yield
|
-1.88%
|
6.87%
|
5.25%
|
7.94%
|
5.21%
|
4.81%
|
3.82%
|
5.16%
|
Price to Book
|
3.02
x
|
1.93
x
|
1.86
x
|
1.72
x
|
1.57
x
|
1.55
x
|
1.45
x
|
1.37
x
|
Nbr of stocks (in thousands)
|
35,427
|
35,427
|
35,427
|
35,127
|
35,130
|
35,032
|
-
|
-
|
Reference price
2 |
8,840
|
6,030
|
6,070
|
5,840
|
5,640
|
5,948
|
5,948
|
5,948
|
Announcement Date
|
6/4/19
|
6/4/20
|
6/4/21
|
6/3/22
|
6/2/23
|
-
|
-
|
-
|
Fiscal Period: April |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
275,596
|
292,615
|
297,305
|
316,247
|
358,742
|
396,306
|
421,001
|
443,869
|
EBITDA
1 |
24,153
|
24,511
|
19,611
|
24,064
|
25,843
|
30,106
|
29,746
|
32,080
|
EBIT
1 |
16,067
|
16,068
|
10,932
|
15,139
|
16,004
|
18,630
|
18,641
|
21,094
|
Operating Margin
|
5.83%
|
5.49%
|
3.68%
|
4.79%
|
4.46%
|
4.7%
|
4.43%
|
4.75%
|
Earnings before Tax (EBT)
1 |
15,624
|
15,930
|
11,767
|
13,125
|
15,882
|
18,763
|
19,805
|
21,443
|
Net income
1 |
9,029
|
9,179
|
6,697
|
7,092
|
9,234
|
10,460
|
10,508
|
11,787
|
Net margin
|
3.28%
|
3.14%
|
2.25%
|
2.24%
|
2.57%
|
2.64%
|
2.5%
|
2.66%
|
EPS
2 |
254.9
|
259.1
|
189.0
|
201.5
|
262.9
|
297.7
|
299.1
|
335.5
|
Free Cash Flow
1 |
-5,197
|
11,922
|
9,025
|
12,213
|
8,336
|
7,760
|
5,855
|
7,406
|
FCF margin
|
-1.89%
|
4.07%
|
3.04%
|
3.86%
|
2.32%
|
1.96%
|
1.39%
|
1.67%
|
FCF Conversion (EBITDA)
|
-
|
48.64%
|
46.02%
|
50.75%
|
32.26%
|
25.78%
|
19.68%
|
23.09%
|
FCF Conversion (Net income)
|
-
|
129.88%
|
134.76%
|
172.21%
|
90.28%
|
74.19%
|
55.72%
|
62.83%
|
Dividend per Share
2 |
55.00
|
55.00
|
55.00
|
55.00
|
60.00
|
61.25
|
65.00
|
72.50
|
Announcement Date
|
6/4/19
|
6/4/20
|
6/4/21
|
6/3/22
|
6/2/23
|
-
|
-
|
-
|
Fiscal Period: April |
2020 S1
|
2021 S1
|
2021 S2
|
2022 Q2
|
2022 S1
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 S1
|
2023 Q3
|
2023 Q4
|
2023 S2
|
2024 Q1
|
2024 Q2
|
2024 S1
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
2025 Q2
|
2025 Q3
|
2025 Q4
|
---|
Net sales
1 |
145,851
|
145,352
|
151,953
|
77,961
|
152,972
|
81,638
|
81,637
|
81,470
|
89,734
|
171,204
|
92,702
|
94,836
|
-
|
94,654
|
99,073
|
193,727
|
102,633
|
101,736
|
102,273
|
105,167
|
108,871
|
107,209
|
EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EBIT
1 |
8,354
|
3,927
|
7,005
|
3,165
|
5,776
|
4,438
|
4,925
|
2,753
|
4,031
|
6,784
|
4,901
|
4,319
|
-
|
3,610
|
5,139
|
8,749
|
5,556
|
4,652
|
3,874
|
5,425
|
5,744
|
5,666
|
Operating Margin
|
5.73%
|
2.7%
|
4.61%
|
4.06%
|
3.78%
|
5.44%
|
6.03%
|
3.38%
|
4.49%
|
3.96%
|
5.29%
|
4.55%
|
-
|
3.81%
|
5.19%
|
4.52%
|
5.41%
|
4.57%
|
3.79%
|
5.16%
|
5.28%
|
5.29%
|
Earnings before Tax (EBT)
1 |
8,439
|
4,524
|
7,243
|
-
|
6,064
|
4,673
|
-
|
2,996
|
4,169
|
7,165
|
4,943
|
3,774
|
-
|
3,942
|
5,485
|
9,427
|
5,604
|
4,959
|
4,099
|
5,650
|
5,969
|
5,891
|
Net income
1 |
4,622
|
2,630
|
4,067
|
2,029
|
3,338
|
2,893
|
861
|
1,704
|
2,100
|
3,804
|
2,824
|
2,606
|
-
|
2,140
|
3,117
|
5,257
|
3,473
|
2,173
|
2,292
|
3,159
|
3,337
|
3,293
|
Net margin
|
3.17%
|
1.81%
|
2.68%
|
2.6%
|
2.18%
|
3.54%
|
1.05%
|
2.09%
|
2.34%
|
2.22%
|
3.05%
|
2.75%
|
-
|
2.26%
|
3.15%
|
2.71%
|
3.38%
|
2.14%
|
2.24%
|
3%
|
3.07%
|
3.07%
|
EPS
|
130.5
|
74.24
|
-
|
57.58
|
94.68
|
82.21
|
24.58
|
48.53
|
59.77
|
108.3
|
80.40
|
74.17
|
-
|
60.93
|
-
|
149.7
|
98.85
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
55.00
|
-
|
-
|
-
|
-
|
60.00
|
60.00
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
12/3/19
|
12/3/20
|
6/4/21
|
12/3/21
|
12/3/21
|
3/4/22
|
6/3/22
|
9/2/22
|
12/2/22
|
12/2/22
|
3/3/23
|
6/2/23
|
6/2/23
|
9/1/23
|
12/6/23
|
12/6/23
|
3/1/24
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: April |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
36,134
|
40,093
|
43,267
|
51,262
|
38,073
|
46,904
|
55,102
|
64,744
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
-5,197
|
11,922
|
9,025
|
12,213
|
8,336
|
7,760
|
5,855
|
7,406
|
ROE (net income / shareholders' equity)
|
9%
|
8.5%
|
5.9%
|
6%
|
7.5%
|
8.02%
|
7.63%
|
7.98%
|
ROA (Net income/ Total Assets)
|
8.93%
|
8.8%
|
6.37%
|
7.71%
|
7.68%
|
8.05%
|
7.6%
|
8%
|
Assets
1 |
101,067
|
104,349
|
105,126
|
91,988
|
120,190
|
129,940
|
138,263
|
147,334
|
Book Value Per Share
2 |
2,931
|
3,131
|
3,267
|
3,386
|
3,599
|
3,834
|
4,101
|
4,350
|
Cash Flow per Share
2 |
365.0
|
374.0
|
309.0
|
338.0
|
420.0
|
668.0
|
646.0
|
-
|
Capex
1 |
5,449
|
5,825
|
5,903
|
8,913
|
11,931
|
8,497
|
9,270
|
9,620
|
Capex / Sales
|
1.98%
|
1.99%
|
1.99%
|
2.82%
|
3.33%
|
2.14%
|
2.2%
|
2.17%
|
Announcement Date
|
6/4/19
|
6/4/20
|
6/4/21
|
6/3/22
|
6/2/23
|
-
|
-
|
-
|
Last Close Price
5,948
JPY Average target price
5,370
JPY Spread / Average Target -9.72% Consensus |
1st Jan change
|
Capi.
|
---|
| +32.95% | 1.32B | | -12.86% | 8.57B | | +6.76% | 419M | | +5.93% | 282M | | +10.56% | 224M | | -8.26% | 85.07M | | -46.83% | 81.99M | | +20.94% | 59.57M |
Retail - Drugs without Grocery
|